OSCA - Olaparib Standard of CAre Study
NCT02262273
·
clinicaltrials.gov ↗
COMPLETED
Status
2123
Enrollment
INDUSTRY
Sponsor class
Conditions
Platinum-sensitive Recurrent Serous Ovarian Cancer
Interventions
OTHER:
Data Collection
Sponsor
AstraZeneca
Collaborators
[object Object]
[object Object]
[object Object]